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Missed
TB
 
More than 40%
of all TB cases go 
undetected or 
unreported
Weak Health Care 
Systems
 
Patients are not being 
treated effectively, 
which contributes to the 
growing threat of drug-
resistant TB
TB/HIV  
Co-Infection
TB is the top killer of people 
living with HIV, whose 
weakened immune systems 
make them more susceptible  
to becoming ill with TB
Drug Resistant TB
TB has grown resistant to our 
best drugs. Drug resistant TB 
is deadlier, costlier and harder 
to treat. It’s now found in every 
country with nearly 500,000 
new cases and 240,000 
deaths in 2016
Efforts to end TB yield 
$43 in return for every 
$1 invested
Tuberculosis is the world’s  
 top infectious disease killer, 
C L A I M I N G 
 1.7 MILLION  
LIVES EACH YEAR
NEARLY 2 
BILLION 
people are infected 
with latent TB
(1/4 of the world’s 
population)
NEARLY 10.4 
MILLION 
people become ill  
with the disease  
each year
TB ANYWHERE IS 
TB EVERYWHERE.
It spreads from person to 
person and can move 
across borders. Fighting TB
ensures a safer America and 
a safer world
W H AT  I S  D R I V I N G  T H E  C O N T I N U E D  S P R E A D  O F  T B ?
More than 50 million 
lives have been 
saved between
2000 and 2016
To bend the curve on TB, the 
global community’s resolve must 
be matched with action or we 
risk unraveling the progress 
we’ve made to date
W H I L E  T H E  W O R L D  H A S  M A D E  P R O G R E S S  A G A I N S T  T B , 
W E  U R G E N T LY  N E E D  T O  D O  E V E N  M O R E
CDC AT THE 
FOREFRONT OF 
INNOVATION 
IN THE  
GLOBAL FIGHT 
AGAINST TB
C D C ’S  E F F O R T S
Expanding access to better 
screening, contact tracing, 
and diagnostics
Providing training and 
technical support to scale 
up use of new and faster 
diagnostic tools
Transforming the approach 
to diagnosing TB among 
children, those living with HIV, 
and other at-risk groups
Through September 
2017, CDC has 
supported TB
screenings for 4.7
million people 
living with HIV
Building on PEPFAR’s
platform, CDC has
launched a new effort
to scale up TB
preventive therapy
for people living with
HIV in high burden 
countries
CDC is working to 
identify the fastest, 
most effective way to 
diagnose TB in children, 
setting the global 
gold standard for 
pediatric diagnosis 
and treatment
CDC is partnering with
World Bank in four
countries in Southern
Africa as part of a 5 year 
effort to expand 
diagnoses to miners, 
their families and 
communities
In India, CDC and
partners are fighting
MDR TB by intensifying
efforts to find missing
cases, boost lab
capacity, and
strengthen infection
control measures
Evaluating better TB 
treatment regimens
Working closely with WHO 
to set the gold standard for 
treating drug-resistant TB
Through PEPFAR*, scaling 
up HIV anti-retroviral 
treatment for people co-
infected with TB and HIV
* U.S. President’s Emergency Plan for AIDS Relief
Identifying TB hotspots to 
target screening efforts
Strengthening basic TB 
infection control programs 
in health facilities and 
communities
Expanding access to TB 
preventive therapy for people 
living with HIV
Developing and strengthening 
surveillance and laboratory 
systems
Expanding workforce and 
research capacity through 
guidelines, mentorship, and 
training programs
Strengthening programs 
through operational research, 
implementation and 
evaluation
CDC is at the forefront of innovation to end TB as a global public health threat. 
CDC is working with Ministries of Health in more than 25 high burden countries to find, cure, and prevent TB
and enhance global efforts. Through a unique combination of scientific and on-the-ground expertise,
CDC is accelerating progress against this epidemic worldwide.
F O R  M O R E  I N F O R M AT I O N
To learn more about CDC’s work to combat TB around the world, 
visit www.cdc.gov/globalhivtb
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We stand at a critical juncture, with an opportunity to elevate worldwide leadership and
commitment in the fight against TB. We must act now to:
L O O K I N G  T O WA R D S  T H E  F U T U R E
Scale up effective
tools and
approaches
Develop new approaches
including less toxic 
drugs and more effective
diagnostics
Strengthen surveillance
systems, lab capacity
and TB infection control
measures
Develop an
effective
vaccine
Encourage greater
accountability, collaboration
and investments from all
corners of the global health
community
F I N D C U R E P R E V E N T E N H A N C E
C D C  K E Y  A C C O M P L I S H M E N T S  A N D  P R O G R A M S
